Once or twice a month I do a post on notable stem cell publications and news, which often but not always include research on iPS cells. It’s sort of a recommended reads kind of post, but I often include one or two things that aren’t necessarily recommended exactly yet seem kind of surprising or novel […]
Cool Cat iPS cells & other notable stem cell pubs/news Read More »
Back in May, the FDA cautioned a stem cell clinic firm called R3 Stem Cell and its leader David Greene about what they were doing. Importantly, the agency indicated that some of R3’s stem cells may be unapproved drug products. FDA and R3 Stem Cell While the FDA didn’t send R3 Stem Cell a formal warning
I’ve been concerned about a stem cell group called MD Stem Cells for many years. Now it comes under more scrutiny from a new must-read piece by Donna Young over at S&P Global. Young’s article reports a puzzling, purported right-to-try (RTT) program that MD Stem Cells appears to working on with Richard Garr. Note that
MD Stem Cells purported Right To Try program Read More »
Over the years I’ve asked patients to talk about their experiences getting a stem cell therapy. One particular post in 2016 has drawn almost 400 comments, many from patients. The insights provided by these patients and the questions asked in the comment stream have provided a unique window into what’s going on out there. There
If you’ve had a stem cell therapy, how was your experience? Read More »
As of October 1, Google was supposed to have banned ads for unproven stem cell clinics and products. This was according to their own new policy. How’s that going? How’s this new Google approach to unproven stem cell marketing working out in the real wild world of the web? To test it, I did over
My B grade to Google on early test of its stem cell clinic ad ban Read More »
Marketing of unproven stem cells has exploded in the past 3 years including some ads for things that sure seem like snake oil to me. Overall, it’s likely that hundreds of thousands of dollars if not more than a million are being spent on advertising of unproven stem cells. While in the past I’ve generally
Discover Magazine runs full-page ‘stem cell’ snake oil ad Read More »
Here is my 2020 Stem Cell and Regenerative medicine Meetings List. Send me your listings if you don’t see your meeting here. Meeting listings are not endorsements and I try to make this list fairly comprehensive so it may even include some meetings that require a second look before deciding on attending. January Tissue Organoids
2020 Stem Cell & Regenerative Medicine Meetings Read More »
After almost a decade blogging about stem cells from just about every angle, it’s interesting to consider trends in the types of questions I get asked such as this much more common one now as compared to 2010: How much is stem cell therapy? What does a patient pay on average for stem cells in
How much is stem cell therapy? 2019 cost poll results Read More »
We here in California have been fortunate to have our own stem cell and regenerative medicine agency called CIRM, standing for the California Institute for Regenerative Medicine. How much has CIRM helped the California economy and has it had broader economic impacts outside of California? How will that impact its future? CIRM has been around
Stem cell cha-ching! CIRM has economic impact in billions, 56K+ jobs Read More »
Every so often I realize I’ve accumulated a bunch of tabs on my browsers of things I need to dive into as time permits, which sometimes translates into a collection of recommended reads here on The Niche. Here are some recommended recent reads in the stem cell/regenerative medicine field and childhood cancer space. It includes
Weekend reads: stem cells, CRISPR, glioma, stroke, RTT & more Read More »